Viewing Study NCT03288350


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2025-12-28 @ 9:56 AM
Study NCT ID: NCT03288350
Status: UNKNOWN
Last Update Posted: 2018-03-22
First Post: 2017-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module